Skip to main content
logo
Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
17.23
-0.32 (-1.82%)
At close: Jun 26, 2026, 4:00 PM EDT
17.27
+0.04 (0.23%)
After-hours: Jun 26, 2026, 7:56 PM EDT

Aurinia Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
2,2162,1111,2651,2936153,238
Market Cap Growth
102.73%66.83%-2.16%110.39%-81.02%84.78%
Enterprise Value
1,9061,787986.021,040233.32,781
Last Close Price
17.2315.958.988.994.3222.87
PE Ratio
7.927.71224.50---
Forward PE
17.2519.6924.06---
PS Ratio
7.437.465.387.374.5971.01
PB Ratio
3.973.633.353.421.526.76
P/TBV Ratio
4.223.833.523.451.546.29
P/FCF Ratio
13.3015.5928.68---
P/OCF Ratio
13.2715.5628.50---
EV/Sales Ratio
6.396.314.195.931.7460.98
EV/EBITDA Ratio
12.4014.3766.81---
EV/EBIT Ratio
14.1917.04----
EV/FCF Ratio
11.4413.2022.36---
Debt / Equity Ratio
0.090.100.170.220.020.02
Debt / EBITDA Ratio
0.480.605.38---
Debt / FCF Ratio
0.410.551.80---
Net Debt / Equity Ratio
-0.55-0.56-0.74-0.67-0.94-0.95
Net Debt / EBITDA Ratio
-2.15-2.60-18.913.163.512.57
Net Debt / FCF Ratio
-1.86-2.39-6.337.404.782.90
Asset Turnover
0.400.430.430.340.260.09
Inventory Turnover
0.660.770.720.440.260.07
Quick Ratio
4.944.694.044.858.7411.85
Current Ratio
5.555.254.575.509.6012.63
Return on Equity (ROE)
51.91%59.91%1.52%-19.92%-24.46%-40.81%
Return on Assets (ROA)
37.63%40.54%-0.66%-18.13%-22.36%-36.05%
Return on Invested Capital (ROIC)
97.74%127.11%-2.61%-98.48%-270.54%-387.09%
Return on Capital Employed (ROCE)
19.22%18.89%-1.01%-20.48%-24.04%-38.69%
Earnings Yield
13.46%12.98%0.45%---
FCF Yield
7.52%6.42%3.49%---
Buyback Yield / Dilution
5.95%5.13%-2.07%-0.93%-9.70%-9.20%
Total Shareholder Return
5.95%5.13%-2.07%-0.93%-9.70%-9.20%
SEC Filings: 10-K · 10-Q